Editas Medicine, Inc. (EDIT)

Trade EDIT now with
2/8/2021 8:07:12 AM Editas Medicine Appoints James Mullen As CEO
1/20/2021 10:56:26 PM Editas Medicine Prices Public Offering Of 3.5 Mln Shares At $66/Shr
1/11/2021 6:11:09 AM Editas Medicine Says Chief Scientific Officer Charles Albright Is Stepping Down On January 15
1/11/2021 6:09:16 AM Editas Says FDA Cleared Initiation Of Safety Phase Of EDIT-301 Clinical Trial
7/7/2020 9:10:47 AM Editas Medicine, Azzur Group Announce Multi-year Agreement For EDIT-301, EDIT-201 Manufacturing
7/7/2020 9:05:55 AM Editas Medicine, Azzur Group Enter Multi-year Agreement For EDIT-301 And EDIT-201 Manufacturing
6/24/2020 12:13:17 AM Editas Medicine Reports Pricing Of Offering Of 6 Mln Common Shares At $31.25/Shr